TRANSCRIPT: LUGPA CME (4) – Advanced Bladder Cancer Clinic: Are You There Yet? Bio Markers and Next Generation Sequencing Presenter: Noah Hahn, MD

Noah Hahn: So I’m going to cover biomarkers and next-generation sequencing. My disclosures are listed here. And I think, first, let’s just talk about what a biomarker is. I just put up here a definition. And this is actually provided by the NIH, in one of their workshops back in 2016.  And I think the […]

Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300.

This study represents a descriptive analysis of preliminary results of a Phase II trial on a novel mixed beam radiotherapy (RT) approach, consisting of carbon ions RT (CIRT) followed by intensity-modulated photon RT, in combination with hormonal therapy, for high-risk prostate cancer (HR PCa) with a special focus on acute toxicity.

X